Human Antithrombin III (Hemarus Therapeutics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman Antithrombin III (Hemarus Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor X inhibitorsThrombin inhibitorsAntithrombin-III replacements
TargetsProthrombinCoagulation factor X
Therapy Area/IndicationsAntithrombin III Deficiency
Global Approved IndicationsAntithrombin III Deficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2015/08/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHemarus Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesHemarus Therapeutics
Inactive CompaniesN/A
Active IndicationsAntithrombin III Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeB01AB02
Related LinksN/A